The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients

BACKGROUND: The hepatitis C virus (HCV) infection has been identified as a leading cause of progressive liver diseases worldwide. Despite new treatment strategies, pegylated interferon alfa-2a (Peg-IFNα-2a), in combination with ribavirin (RBV), still represents the gold standard of therapy for hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokharaei-Salim, Farah, Salehi-Vaziri, Mostafa, Sadeghi, Farzin, Esghaei, Maryam, Monavari, Seyed Hamidreza, Alavian, Seyed Moayed, Fakhim, Shahin, Keyvani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908614/
https://www.ncbi.nlm.nih.gov/pubmed/27313635
http://dx.doi.org/10.5812/hepatmon.35597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908614/
https://www.ncbi.nlm.nih.gov/pubmed/27313635
http://dx.doi.org/10.5812/hepatmon.35597

Ejemplares similares